Description
BPC-157 TB-500 blend — PSPeptides’ dual-peptide regenerative research formulation combining 5mg BPC-157 and 5mg TB-500 (Thymosin Beta-4 fragment) in a single lyophilized vial. Each component of this BPC-157 TB-500 blend delivers ≥99% purity verified by independent HPLC and mass spectrometry. This formulation is designed for researchers investigating multi-pathway tissue repair, musculoskeletal regeneration, and angiogenesis in preclinical laboratory settings.
What Is the BPC-157 TB-500 Blend?
The BPC-157 TB-500 blend — often called the “Wolverine Stack” in research communities — pairs two of the most extensively studied tissue-repair peptides in preclinical science. BPC-157 (Body Protection Compound-157) is a stable 15-amino acid gastric pentadecapeptide (CAS 137525-51-8) originally isolated from human gastric juice. TB-500 is a synthetic analog of the Thymosin Beta-4 protein fragment (CAS 77591-33-4), a 43-amino acid peptide found at high concentrations in platelets, wound fluid, and virtually all human and animal cells. This BPC-157 TB-500 blend provides researchers with both compounds at a fixed 1:1 ratio in a single verified vial. Learn more in our BPC-157 TB-500 blend complete guide and the dedicated Wolverine Stack research overview.
Key Research Applications
- Tendon and connective tissue repair: The BPC-157 TB-500 blend provides both localized fibroblast stimulation via BPC-157 and systemic cell migration via TB-500, making it a powerful dual-pathway tool for tendon injury research.
- Musculoskeletal healing: Preclinical models show this combination accelerates recovery in muscle, ligament, and bone tissue, with each component targeting distinct cellular repair mechanisms.
- Angiogenesis and vascular support: BPC-157 activates VEGFR2 while TB-500 promotes actin polymerization and endothelial migration — together supporting robust neovascularization at injury sites.
- Anti-inflammatory modulation: Both peptides independently down-regulate pro-inflammatory cytokines and NF-κB signaling, making the BPC-157 TB-500 blend valuable in inflammatory pathway studies.
- Gastrointestinal cytoprotection: BPC-157 has been studied extensively for its protective effects on gastric and intestinal mucosa, adding a research dimension absent from TB-500 alone.
Product Specifications
| Composition | BPC-157 (5mg) + TB-500 (5mg) |
| Total Content | 10mg per vial |
| Purity | ≥99% per component (HPLC & mass spectrometry verified) |
| Form | Lyophilized powder |
| Storage | –20°C long-term; 4°C short-term (up to 4 weeks); protect from light |
| Testing | Batch-specific COA included |
| Origin | US manufactured, third-party tested |
| BPC-157 CAS | 137525-51-8 |
| TB-500 CAS | 77591-33-4 |
Reviews
There are no reviews yet.